Muutke küpsiste eelistusi

Cancer Clinical Trials: Proactive Strategies 1st ed. 2007. Corr. 3rd printing 2007 [Kõva köide]

  • Formaat: Hardback, 320 pages, kõrgus x laius: 235x156 mm, kaal: 1450 g, XX, 320 p., 1 Hardback
  • Sari: Cancer Treatment and Research 132
  • Ilmumisaeg: 09-Nov-2006
  • Kirjastus: Springer-Verlag New York Inc.
  • ISBN-10: 0387332243
  • ISBN-13: 9780387332246
Teised raamatud teemal:
  • Kõva köide
  • Hind: 141,35 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 166,29 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 320 pages, kõrgus x laius: 235x156 mm, kaal: 1450 g, XX, 320 p., 1 Hardback
  • Sari: Cancer Treatment and Research 132
  • Ilmumisaeg: 09-Nov-2006
  • Kirjastus: Springer-Verlag New York Inc.
  • ISBN-10: 0387332243
  • ISBN-13: 9780387332246
Teised raamatud teemal:
Clinical trials remain the most important vehicle for improving the care of cancer patients. This text presents the fundamental components and challenges involving clinical investigations. Leading experts discuss the critical issues covering the spectrum of important topics from planning to application. The book has a foreword by Samuel A. Wells, Jr., MD, Professor of Surgery, Duke University Medical Center, Durham, NC, former Director of the American College of Surgeons and Founder of the American College of Surgeons Oncology Group. The objective of this book is to bring the issues of cancer clinical trials into focus so that proactive strategies may be developed to make such trials more user-friendly. Ultimately, the cancer patients will be benefited.
Contributors vii
Foreword xiii
Preface xvii
Acknowledgement xix
1. Historical Perspective and Evolving Concerns for Human Research
1(10)
Bernard Lo and Nesrin Garan
2. Cancer Trials and the Institutional Review Board (IRB)
11(20)
Scott Kurtzman and Zita Lazzarini
3. NCI's Cancer Therapy Evaluation Program: A Commitment to Treatment Trials
31(20)
Jeffrey S. Abrams, Anthony Murgo and Michaele C. Christian
4. Practical Guide for Cancer Clinical Investigators
51(60)
Steven Hirschfeld
5. The Role of Cooperative Groups in Cancer Clinical Trials
111(20)
Ann M. Mauer, Elizabeth S. Rich and Richard L. Schilsky
6. The Advocate Role in Clinical Study Development and Partnering with Patient Advocates in Your Local Institution
131(12)
Barbara Parker
7. The National Breast Cancer Coalition: Setting the Standard for Advocate Collaboration in Clinical Trials
143(14)
Fran Visco
8. The Role of the Principal Investigator in Cancer Clinical Trials
157(22)
Stanley P.L. Leong
9. The Audit Process and How to Ensure a Successful Audit
179(20)
Y. Nancy You, Lisa Jacobs, Elizabeth Martinez and David M. Ota
10. The Privacy Rule (HIPAA) As It Relates To Clinical Research 199(10)
John M. Harrelson and John M. Falletta
11. The Commission on Cancer, American College of Surgeons' Response to HIPAA 209(10)
E. Greer Gay
12. Ethical and Legal Issues in the Conduct of Cancer Clinical Trials 219(12)
Gerianne J. Sands and Peggy A. Means
13. The Role of the Office of Research Integrity in Cancer Clinical Trials 231(10)
Peter Abbrecht, Nancy Davidian, Samuel Merrill and Alan R. Price
14. Strategies for the Administration of a Clinical Trial Infrastructure: Lessons from a Comprehensive Cancer Center 241(34)
Leonard A. Zwelling and Carleen A. Brunelli
15. The Clinical Research Process: Building a System in Harmony with Its Users 275(16)
Greg Koski
16. Cancer Research and Clinical Trial in Action: An Important Exercise Before You Embark on Your Study 291(20)
Stanley P.L. Leong, Larry Carbone and Scott Kurtzman
Index 311